0 results for 'DuPont'
The Future of FDA Policy: Reflections From the Summer of 'Chevron'
Sheppard Mullin attorneys discuss 'Loper Bright Enterprises v. Raimondo' and include the considerations stemming from the decision, both generally and with respect to FDA practice, specifically. They write: "Now, after having spent the summer pouring over cases, articles, and thought leadership on the matter, we're not sure the win is so sweeping—especially in the U.S. Food & Drug Administration arena."Defendants in Chocolate Factory Explosion Litigation Lose Bid to Transfer Out of Philadelphia
After the parties spent more than a year conducting venue discovery, the defendants failed to convince the court that the companies being sued did not conduct sufficient business in Philadelphia for the lawsuits to be situated there.Alito Reports Concert Tickets From German Socialite in New Disclosure Form
Friday's 2023 disclosure came after the justice sought and received a three-month filing extension from the judiciary, the only member of the U.S. Supreme Court to need extra time to prepare their form.Three's Company: Can a Nonsignatory to an Arbitration Agreement Compel or Be Compelled to Arbitrate?
"Courts in New Jersey ... emphasize strong public policy favoring arbitration to resolve disputes and require liberality in construing contracts in favor of arbitration," write Archer's Alexis M. Way and Marie E. Lihotz.Litigation Leaders: Don McMinn of Hollingsworth on Going Where the Work Takes You
"We have argued before federal and state courts nationwide, and we do not shy away from going toe-to-toe with plaintiffs' counsel in their preferred home-turf courthouses, whether that be suburban California or small-town Mississippi."View more book results for the query "DuPont"
Rising PFAS Lawsuits, Increased Regulation Put the Squeeze on Defendants
"The litigation is driving the PFAS manufacturers to stop making them, which trickles down as a supply chain obsolescence issue," industry consultant Cally Egdren said.ExxonMobil Argues Co-Defendant's Settlement Barred Claims That Yielded $725M Benzene Verdict
The company asserted in a recent post-trial brief that the plaintiffs were not entitled to recover against ExxonMobil at all because they had already been compensated by another defendant for their injuries.Chemical Firm BASF Strikes $316.5M Settlement With Drinking Water Providers
Lawyers suing over "forever chemicals" in the nation's drinking water supplies announced their fourth settlement on Tuesday.Phila. Jury Hits ExxonMobil With $725.5M Verdict Over Carcinogen in Gasoline
The jury determined that Paul Gill developed acute myeloid leukemia as a result of his exposure to ExxonMobil's product, awarding $725 million in compensatory noneconomic damages for Gill, plus $500,000 to his wife for loss of consortium.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now
2025 State Legislative Sessions
Brought to you by LexisNexis®
Download Now
Retention & Online Reputation for Law Firms: 2025 Guide
Brought to you by Amazing Workplace, Inc.
Download Now
Europe's Escalating Regulatory Framework: Mapping Efforts to Mitigate Supply Chain Risks
Brought to you by LRN
Download Now